PubMed for id: 8772

Year	Number of Results
1995	2
1996	4
1997	10
1998	5
1999	6
2000	12
2001	8
2002	23
2003	18
2004	16
2005	22
2006	17
2007	11
2008	15
2009	22
2010	24
2011	31
2012	20
2013	10
2014	17
2015	9
2016	20
2017	11
2018	11
2019	10
2020	8
2021	10
2022	9
2023	6
2024	3

1

Combined germline and somatic human FADD mutations cause autoimmune lymphoproliferative syndrome.

Pellé O, Moreno S, Lorenz MR, Riller Q, Fuehrer M, Stolzenberg MC, Maccari ME, Lenoir C, Cheminant M, Hinze T, Hebart HF, König C, Schvartz A, Schmitt Y, Vinit A, Henry E, Touzart A, Villarese P, Isnard P, Neveux N, Landman-Parker J, Picard C, Fouyssac F, Neven B, Grimbacher B, Speckmann C, Fischer A, Latour S, Schwarz K, Ehl S, Rieux-Laucat F, Rensing-Ehl A, Magérus A. Pellé O, et al. J Allergy Clin Immunol. 2024 Jan;153(1):203-215. doi: 10.1016/j.jaci.2023.09.028. Epub 2023 Oct 2. J Allergy Clin Immunol. 2024. PMID: 37793571

2

Prognostic significance and immune correlates of FADD in penile squamous cell carcinoma.

Xue T, Yan R, Li Z, Guo S, Xiao X, Jin J, Jiang L, Ma H, Wu C, Liu T, Wei L, Xiong L, Zhou F, Yao K, Liu R, Han H. Xue T, et al. Virchows Arch. 2023 May;482(5):869-878. doi: 10.1007/s00428-023-03514-9. Epub 2023 Feb 23. Virchows Arch. 2023. PMID: 36813950

3

A Dual Role for FADD in Human Precursor T-Cell Neoplasms.

Marín-Rubio JL, Vela-Martín L, Gudgeon J, Pérez-Gómez E, Sidgwick FR, Trost M, Cunningham DL, Santos J, Fernández-Piqueras J, Villa-Morales M. Marín-Rubio JL, et al. Int J Mol Sci. 2022 Dec 2;23(23):15157. doi: 10.3390/ijms232315157. Int J Mol Sci. 2022. PMID: 36499482 Free PMC article.

4

The Classical Apoptotic Adaptor FADD Regulates Glycolytic Capacity in Acute Lymphoblastic Leukemia.

Zhou W, Lai Y, Zhu J, Xu X, Yu W, Du Z, Wu L, Zhang X, Hua Z. Zhou W, et al. Int J Biol Sci. 2022 May 1;18(8):3137-3155. doi: 10.7150/ijbs.68016. eCollection 2022. Int J Biol Sci. 2022. PMID: 35637951 Free PMC article.

5

Loss of FADD and Caspases Affects the Response of T-Cell Leukemia Jurkat Cells to Anti-Cancer Drugs.

Mrkvová Z, Portešová M, Slaninová I. Mrkvová Z, et al. Int J Mol Sci. 2021 Mar 7;22(5):2702. doi: 10.3390/ijms22052702. Int J Mol Sci. 2021. PMID: 33800107 Free PMC article.

6

Overexpression of FADD and Bcl-XS proteins as novel prognostic biomarkers for surgically resected non-small cell lung cancer.

Chen L, Xie G, Feng J, Wen Q, Zang H, Lu J, Zhan Y, Fan S. Chen L, et al. Cancer Biomark. 2021;30(2):145-154. doi: 10.3233/CBM-190018. Cancer Biomark. 2021. PMID: 33104018

7

Novel Compound Heterozygote Variations in FADD Identified to Cause FAS-Associated Protein with Death Domain Deficiency.

Kohn LA, Long JD, Trope EC, Kuo CY. Kohn LA, et al. J Clin Immunol. 2020 May;40(4):658-661. doi: 10.1007/s10875-020-00779-6. Epub 2020 Apr 29. J Clin Immunol. 2020. PMID: 32350755 Free PMC article. No abstract available.

8

FADD Phosphorylation Modulates Blood Glucose Levels by Decreasing the Expression of Insulin-Degrading Enzyme.

Lin Y, Liu J, Chen J, Yao C, Yang Y, Wang J, Zhuang H, Hua ZC. Lin Y, et al. Mol Cells. 2020 Apr 30;43(4):373-383. doi: 10.14348/molcells.2020.2198. Mol Cells. 2020. PMID: 32191993 Free PMC article.

9

S194-P-FADD as a marker of aggressiveness and poor prognosis in human T-cell lymphoblastic lymphoma.

Marín-Rubio JL, Pérez-Gómez E, Fernández-Piqueras J, Villa-Morales M. Marín-Rubio JL, et al. Carcinogenesis. 2019 Oct 16;40(10):1260-1268. doi: 10.1093/carcin/bgz041. Carcinogenesis. 2019. PMID: 30805584

10

FADD at the Crossroads between Cancer and Inflammation.

Mouasni S, Tourneur L. Mouasni S, et al. Trends Immunol. 2018 Dec;39(12):1036-1053. doi: 10.1016/j.it.2018.10.005. Epub 2018 Nov 3. Trends Immunol. 2018. PMID: 30401514 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

353 results

Results by year